Efficacy and Treatment Satisfaction of Once-daily Insulin Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The SWITCH Pilot Study

R. Schiel; U. Müller

doi:10.1055/s-2007-985367

Efficacy and Treatment Satisfaction of Once-daily Insulin Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The SWITCH Pilot Study

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-2007-985367 ◽

2007 ◽

Vol 116 (01) ◽

pp. 58-64 ◽

Cited By ~ 8

Author(s):

R. Schiel ◽

U. Müller

Keyword(s):

Type 2 Diabetes ◽

Pilot Study ◽

Insulin Glargine ◽

Treatment Satisfaction ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Once Daily ◽

Oral Antidiabetic

Download Full-text

Efficacy and Treatment Satisfaction of Once-Daily Insulin Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The Switch Pilot Study

Experimental and Clinical Endocrinology & Diabetes ◽

10.1055/s-2007-984445 ◽

2007 ◽

Vol 115 (10) ◽

pp. 627-633 ◽

Cited By ~ 13

Author(s):

R. Schiel ◽

Ulrich A. Müller

Keyword(s):

Type 2 Diabetes ◽

Pilot Study ◽

Insulin Glargine ◽

Treatment Satisfaction ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Once Daily ◽

Oral Antidiabetic

Download Full-text

Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes a simulation with the Diabetes Mellitus Model (DMM)

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cpp45623 ◽

2007 ◽

Vol 45 (12) ◽

pp. 623-630 ◽

Cited By ~ 4

Author(s):

H.U. Janka ◽

F. Hessel ◽

S. Walzer ◽

E. Müller

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycemic Control ◽

Insulin Glargine ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Oral Antidiabetic

Download Full-text

The efficacy of once-daily liraglutide as an add-on to oral antidiabetic agents on weight reduction and glycemic control in obese patients with inadequately controlled type 2 diabetes: a retrospective analysis in relation to liraglutide dose escalation within a 7-month treatment period

International Journal of Diabetes in Developing Countries ◽

10.1007/s13410-020-00878-5 ◽

2020 ◽

Author(s):

Abbas Mahdi Rahmah ◽

Jameelah Kadhim Taher Al-Isawi ◽

Osama Abbas Mahdi

Keyword(s):

Type 2 Diabetes ◽

Glycemic Control ◽

Dose Escalation ◽

Weight Reduction ◽

Obese Patients ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Once Daily ◽

Oral Antidiabetic

Download Full-text

PDB26 COMPARATIVE EVALUATION OF THE LONG-TERM COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 AND INSULIN GLARGINE IN A SUB-POPULATION OF POORLY CONTROLLED PATIENTS WITH TYPE-2 DIABETES RECEIVING ORAL ANTIDIABETIC AGENTS

Value in Health ◽

10.1016/s1098-3015(10)67645-0 ◽

2005 ◽

Vol 8 (6) ◽

pp. A162

Author(s):

D Cobden ◽

L Nicklasson ◽

P Raskin ◽

A Garber ◽

JA Ray ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Comparative Evaluation ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

Biphasic Insulin Aspart 30

Download Full-text

Insulin glargine plus oral antidiabetic agents in comparison with biphasic insulin in type 2 diabetes: a UK cost comparison

The British Journal of Diabetes ◽

10.1177/1474651411406802 ◽

2011 ◽

Vol 11 (3) ◽

pp. 141-144

Author(s):

David Owens ◽

Carl Tilling ◽

Martin Keech

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Cost Comparison ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Biphasic Insulin ◽

Oral Antidiabetic

Download Full-text

PDB20 COMPARISON OF THE COST TO REACH A1C TARGETS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS ON ORAL ANTIDIABETIC AGENTS AND EITHER BIPHASIC INSULIN ASPART 70/30 OR INSULIN GLARGINE

Value in Health ◽

10.1016/s1098-3015(10)62953-1 ◽

2005 ◽

Vol 8 (3) ◽

pp. 358

Author(s):

D Cobden ◽

E Allen ◽

M Botteman

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Insulin Glargine ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Biphasic Insulin ◽

Oral Antidiabetic ◽

The Cost

Download Full-text

Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice*

International Journal of Clinical Practice ◽

10.1111/j.1742-1241.2007.01598.x ◽

2007 ◽

Vol 61 (12) ◽

pp. 2009-2018 ◽

Cited By ~ 13

Author(s):

H. Hammer ◽

A. Klinge

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Insulin Glargine ◽

Daily Practice ◽

Premixed Insulin ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Insulin Effect ◽

Oral Antidiabetic

Download Full-text

Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial

Diabetes Obesity and Metabolism ◽

10.1111/j.1463-1326.2008.00873.x ◽

2008 ◽

Vol 10 (5) ◽

pp. 387-399 ◽

Cited By ~ 44

Author(s):

M. Davies ◽

F. Lavalle-González ◽

F. Storms ◽

R. Gomis ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Oral Antidiabetic

Download Full-text

Cost‐effectiveness of exenatide twice daily vs insulin glargine as add‐on therapy to oral antidiabetic agents in patients with type 2 diabetes in China

Diabetes Obesity and Metabolism ◽

10.1111/dom.12991 ◽

2017 ◽

Vol 19 (12) ◽

pp. 1688-1697 ◽

Cited By ~ 5

Author(s):

Shuyan Gu ◽

Xiaoyong Wang ◽

Qing Qiao ◽

Weiguo Gao ◽

Jian Wang ◽

...

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Insulin Glargine ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Oral Antidiabetic

Download Full-text

Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents

Clinical Therapeutics ◽

10.1016/j.clinthera.2011.09.022 ◽

2011 ◽

Vol 33 (11) ◽

pp. 1698-1712 ◽

Cited By ~ 13

Author(s):

William J. Valentine ◽

Andrew J. Palmer ◽

Morten Lammert ◽

Jakob Langer ◽

Michael Brändle

Keyword(s):

Type 2 Diabetes ◽

Cost Effectiveness ◽

Oral Antidiabetic Agents ◽

Antidiabetic Agents ◽

Oral Antidiabetic ◽

Exenatide Bid

Download Full-text

Efficacy and Treatment Satisfaction of Once-daily Insulin Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The SWITCH Pilot Study

Efficacy and Treatment Satisfaction of Once-Daily Insulin Glargine Plus One or Two Oral Antidiabetic Agents Versus Continuing Premixed Human Insulin in Patients with Type 2 Diabetes Previously on Long-term Conventional Insulin Therapy: The Switch Pilot Study

Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes  a simulation with the Diabetes Mellitus Model (DMM)

The efficacy of once-daily liraglutide as an add-on to oral antidiabetic agents on weight reduction and glycemic control in obese patients with inadequately controlled type 2 diabetes: a retrospective analysis in relation to liraglutide dose escalation within a 7-month treatment period

PDB26 COMPARATIVE EVALUATION OF THE LONG-TERM COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 AND INSULIN GLARGINE IN A SUB-POPULATION OF POORLY CONTROLLED PATIENTS WITH TYPE-2 DIABETES RECEIVING ORAL ANTIDIABETIC AGENTS

Insulin glargine plus oral antidiabetic agents in comparison with biphasic insulin in type 2 diabetes: a UK cost comparison

PDB20 COMPARISON OF THE COST TO REACH A1C TARGETS IN PATIENTS WITH TYPE-2 DIABETES MELLITUS ON ORAL ANTIDIABETIC AGENTS AND EITHER BIPHASIC INSULIN ASPART 70/30 OR INSULIN GLARGINE

Patients with type 2 diabetes inadequately controlled on premixed insulin: effect of initiating insulin glargine plus oral antidiabetic agents on glycaemic control in daily practice*

Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial

Cost‐effectiveness of exenatide twice daily vs insulin glargine as add‐on therapy to oral antidiabetic agents in patients with type 2 diabetes in China

Evaluating the Long-Term Cost-Effectiveness of Liraglutide Versus Exenatide BID in Patients With Type 2 Diabetes Who Fail to Improve With Oral Antidiabetic Agents

Insulin glargine added to therapy with oral antidiabetic agents improves glycemic control and reduces long-term complications in patients with type 2 diabetes a simulation with the Diabetes Mellitus Model (DMM)